Linking intraoperative nociception to postoperative pain: a secondary comparative analysis of opioid-free and opioid-based anesthesia.
Daniel Widarsson Norbeck, Henrik Öhrström, Sophie Lindgren...
https://pubmed.ncbi.nlm.nih.gov/41805550/Actively Recruiting
Led by Göteborg University · Updated on 2026-01-07
220
Participants Needed
2
Research Sites
82 weeks
Total Duration
Researchers are evaluating opioid-free and opioid-sparing care pathways compared to conventional opioid-based treatment in patients undergoing obesity surgery. The study aims to assess the short-, medium-, and long-term effects on cognitive and physical recovery after surgery, opioid usage up to 24 months post-discharge, clinical monitoring of pain responses during surgery, and patient experiences related to quality of life, self-efficacy, and economic outcomes. The study includes two intervention phases testing pharmacological and non-pharmacological treatments. The control group receives standard opioid-based anesthesia and postoperative pain management with drugs like Remifentanil and Oxycodone. Intervention groups receive opioid-free anesthesia using drugs such as Dexmedetomidine, Esketamine, Lidocaine, and Transcutaneous Nerve Stimulation TENS. Phase 2 adds a person-centred care approach throughout perioperative and up to four weeks after discharge. Treatments are administered during the perioperative and postoperative periods with specific dosing and monitoring. Participants will be closely monitored for pain levels, opioid consumption, and quality of recovery from surgery up to 24 months. Assessments include postoperative pain scores, quality of life questionnaires, self-efficacy scales, hospital readmission rates, and mortality. Clinical monitoring during surgery uses nociception level measurements. Patient experiences and economic evaluations are also recorded. The total follow-up involves multiple timepoints from immediate postoperative to two years after surgery.
CONDITIONS
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
A
Axel Wolf, RN, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Göteborg University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Hospital stay, approximately 2 days
Participants undergo laparoscopic obesity surgery with either an opioid-sparing or conventional opioid-based anesthesia and pain management protocol.
Continuous care during hospital stay until discharge
Duration - Up to 24 months post-surgery
Participants are monitored for recovery, pain levels, opioid consumption, and quality of life after surgery through outpatient assessments.
Visits at 20 minutes, 40 minutes, 24-72 hours, 14 days, 30 days, 3 months, 6 months, 12 months, and 24 months
Duration - Up to 4 weeks post-discharge
Participants in Phase 2 receive person-centred care throughout the perioperative period and up to 4 weeks after discharge to support recovery.
Visits aligned with routine care and study assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Daniel Widarsson Norbeck, Henrik Öhrström, Sophie Lindgren...
https://pubmed.ncbi.nlm.nih.gov/41805550/Alexander Olausson, Pether Jildenstål, Paulin Andréll...
https://pubmed.ncbi.nlm.nih.gov/40371564/Göteborg University
Lead Sponsor